Literature DB >> 8065547

Neuropeptide Y (NPY) enhances proliferation of human colonic lamina propria lymphocytes.

Y Elitsur1, G D Luk, M Colberg, M S Gesell, J Dosescu, J A Moshier.   

Abstract

Neuropeptide Y (NPY) is one member of a family of peptides with a wide range of physiological effects on the CNS, cardiovascular, and respiratory systems. NPY is widely distributed throughout the peripheral and central nervous systems. It has also been found within the colon, liver and gallbladder in close anatomic proximity to the mucosal immune system. In this study, we investigated the effect of NPY on human gut mucosal immune function. We examined colonic lamina propria lymphocyte (LPL) proliferation by measuring DNA synthesis, ornithine decarboxylase (ODC) activity, and polyamine biosynthesis. NPY enhanced ODC activity and polyamine biosynthesis in Con A-stimulated LPL, and enhanced thymidine incorporation into Con A-stimulated LPL but not into monocyte-depleted LPL. Moreover, exogenous IL1-beta partially restored NPY's stimulatory effect on monocyte-depleted LPL DNA synthesis. Our results demonstrate that NPY enhances human colonic LPL proliferation and that this effect is partially IL1-beta dependent. Our data also suggest that NPY's effect may be mediated via polyamine biosynthesis. We postulate that the NPY may have an important impact on human mucosal immune function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065547     DOI: 10.1016/0143-4179(94)90113-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

1.  Influence of acute and chronic treadmill exercise on rat plasma lactate and brain NPY, L-ENK, DYN A1-13.

Authors:  Jia-Xu Chen; Xin Zhao; Guang-Xin Yue; Zhu-Feng Wang
Journal:  Cell Mol Neurobiol       Date:  2006-07-21       Impact factor: 5.046

2.  Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.

Authors:  Bindu Chandrasekharan; Darra Boyer; Joshua A Owens; Alexandra A Wolfarth; Bejan J Saeedi; Tanvi Dhere; Heba Iskandar; Andrew S Neish
Journal:  Inflamm Bowel Dis       Date:  2022-03-30       Impact factor: 7.290

3.  FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system.

Authors:  Y Elitsur; X Liu; J Dosescu; J A Moshier
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 4.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

Review 5.  Current Insights Into the Role of Neuropeptide Y in Skin Physiology and Pathology.

Authors:  Zoya T Anderson; Alex D Dawson; Andrzej T Slominski; Melissa L Harris
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

Review 6.  Immunomodulatory Role of Neuropeptides in the Cornea.

Authors:  Sudan Puri; Brendan M Kenyon; Pedram Hamrah
Journal:  Biomedicines       Date:  2022-08-16

Review 7.  Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect.

Authors:  Wei-Can Chen; Yi-Bin Liu; Wei-Feng Liu; Ying-Ying Zhou; He-Fan He; Shu Lin
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.